🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Pacific Biosciences of California (PACB)

NASDAQ
Currency in USD
2.450
-0.200(-7.55%)
Closed
After Hours
2.050-0.400(-16.327%)
PACB Scorecard
Full Analysis
Quickly burning through cash
Unusual Post-Market activity
Fair Value
Day's Range
2.3802.720
52 wk Range
1.16010.650
Prev. Close
2.65
Open
2.71
Day's Range
2.38-2.72
52 wk Range
1.16-10.65
Volume
18,101,494
Average Volume (3m)
8,309,585
1-Year Change
-63.38%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
PACB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.091
Upside
+26.163%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year
Show more

Pacific Biosciences of California Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

InvestingPro Research for Pacific Biosciences of California


Genomics Headwinds
PacBio faces challenges in the genomics industry, with revised guidance reflecting slower sales cycles and macroeconomic pressures on its Revio system placements
Financial Resilience
Explore PacBio's ambitious $75 million cost-out run-rate target and its goal to achieve free cash flow positivity by 2026, showcasing strategic financial management
Market Dynamics
Delve into the complex interplay of macroeconomic factors, capital expenditure trends, and PacBio's innovative commercial strategies in the evolving genomics secto
Analyst Perspectives
Barclays Capital Inc. sets price targets ranging from $2.00 to $3.00, reflecting cautious optimism amidst PacBio's efforts to navigate market challenges
Read full SWOT analysis

Compare PACB to Peers and Sector

Metrics to compare
PACB
Peers
Sector
Relationship
P/E Ratio
−1.7x−8.0x−0.6x
PEG Ratio
0.15−0.060.00
Price/Book
1.4x2.5x2.6x
Price / LTM Sales
3.5x4.8x3.3x
Upside (Analyst Target)
2.0%27.6%45.3%
Fair Value Upside
Unlock13.4%6.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1.5
Dividend Yield
-
Annualized payout
-
5-Years Growth
-
Growth Streak

People Also Watch

3.17
EDIT
-3.35%
51.73
SNY
+0.92%
222.18
ALGN
-1.19%
0.060
LILMF
+0.00%

FAQ

What Is the Pacific Biosciences (PACB) Stock Price Today?

The Pacific Biosciences stock price today is 2.45

What Stock Exchange Does Pacific Biosciences Trade On?

Pacific Biosciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Pacific Biosciences?

The stock symbol for Pacific Biosciences is "PACB."

What Is the Pacific Biosciences Market Cap?

As of today, Pacific Biosciences market cap is 666.33M.

What is Pacific Biosciences Earnings Per Share?

The Pacific Biosciences EPS is -1.50.

What Is the Next Pacific Biosciences Earnings Date?

Pacific Biosciences will release its next earnings report on Feb 13, 2025.

From a Technical Analysis Perspective, Is PACB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.